New Treatments Options a ‘Game-Changer’ in Esophagogastric Cancer

For the first time, a third-line treatment in heavily pretreated Western patients with chemotherapy-refractory esophagogastric cancer has demonstrated clinically meaningful antitumor activity, durable responses, encouraging long-term overall survival (OS), and a manageable safety profile, researchers said. Results from 160 patients in the ongoing CheckMate-032 study showed an objective response […]

Leave a Reply